MetaCap

CVRx (CVRX) vs NANO-X IMAGING LTD (NNOX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

CVRx (CVRX) has outperformed NANO-X IMAGING LTD (NNOX) over the past year, losing 81.6% versus a loss of 86.9%. Over five years, CVRX leads with a -89.3% price change compared with -97.5% for NNOX. CVRx is the larger company by market cap ($44.8 million vs $44.5 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CVRX-81.56%NNOX-86.92%
+24%-34%-92%
Oct 8, 20251 yearOct 8, 2026
CVRX-89.83%NNOX-97.42%
+100%-4%-107%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CVRX versus NNOX key metrics
MetricCVRXNNOX
Share price$1.68$0.5663
Market cap$44.76M$44.50M
1-day change+0.60%-4.82%
YTD return-76.34%-79.77%
1-year return-81.56%-86.92%
5-year return-89.27%-97.51%
EPS (TTM)$-1.97$-1.72
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$11.30$4.71
52-week low$1.50$0.55
Distance from 52-week high-85.13%-87.96%
Analyst consensusnonenone
Avg. price target upside+172.62%+629.30%
Average volume922.12K1.17M
Shares outstanding26.64M78.59M
Employees223197
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About CVRx

CVRX stock →

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.

Healthcare · Medical Devices · 223 employees

About NANO-X IMAGING LTD

NNOX stock →

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source.

Healthcare · Medical Devices · 197 employees

CVRX vs NNOX FAQ

Which is bigger, CVRx or NANO-X IMAGING LTD?

CVRx (CVRX) is larger, with a market capitalization of $44.76M compared with $44.50M for NANO-X IMAGING LTD (NNOX).

Which stock has performed better over the past year, CVRX or NNOX?

CVRX returned -81.56% over the past 12 months, compared with -86.92% for NNOX (price return, excluding dividends). Past performance does not predict future results.

Are CVRx and NANO-X IMAGING LTD in the same industry?

Yes. Both are classified in the Medical Devices industry within the Healthcare sector.

More comparisons